01 1Sunovion Pharmaceuticals Canada Inc.
02 4Sunovion Pharmaceuticals Canada Inc. (as agent for Cubist Pharmaceuticals LLC)
01 22344318
02 22743326
03 12781666
01 3DAPTOMYCIN
02 2Daptomycin
01 3POWDER FOR SOLUTION
02 2Powder for solution
01 22019-09-24
02 22021-01-18
03 12030-11-23
Patent Expiration Date : 2019-09-24
Date Granted : 2006-07-04
Brand Name : CUBICIN
Patent Number : 2344318
Filing Date : 1999-09-24
Strength per Unit : 500mg / vial
Dosage Form : Powder for solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2019-09-24
Date Granted : 2006-07-04
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2021-01-18
Date Granted : 2015-04-07
Brand Name : CUBICIN
Patent Number : 2743326
Filing Date : 2001-01-18
Strength per Unit : 500mg / vial
Dosage Form : Powder for solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2021-01-18
Date Granted : 2015-04-07
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-11-23
Date Granted : 2017-02-21
Brand Name : CUBICIN RF
Patent Number : 2781666
Filing Date : 2010-11-23
Strength per Unit : 500 mg / vial
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2030-11-23
Date Granted : 2017-02-21
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2019-09-24
Date Granted : 2006-07-04
Brand Name : CUBICIN RF
Patent Number : 2344318
Filing Date : 1999-09-24
Strength per Unit : 500 mg / vial
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2019-09-24
Date Granted : 2006-07-04
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2021-01-18
Date Granted : 2015-04-07
Brand Name : CUBICIN RF
Patent Number : 2743326
Filing Date : 2001-01-18
Strength per Unit : 500 mg / vial
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2021-01-18
Date Granted : 2015-04-07
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
